Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Total Liabilities: 2010-2024

Historic Total Liabilities for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to $7.1 million.

  • Sunshine Biopharma's Total Liabilities rose 45.25% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 45.25%. This contributed to the annual value of $7.1 million for FY2024, which is 14.99% up from last year.
  • Per Sunshine Biopharma's latest filing, its Total Liabilities stood at $7.1 million for FY2024, which was up 14.99% from $6.1 million recorded in FY2023.
  • Sunshine Biopharma's 5-year Total Liabilities high stood at $7.6 million for FY2022, and its period low was $2.0 million during FY2021.
  • Moreover, its 3-year median value for Total Liabilities was $7.1 million (2024), whereas its average is $6.9 million.
  • In the last 5 years, Sunshine Biopharma's Total Liabilities soared by 282.49% in 2022 and then declined by 19.39% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Total Liabilities (Yearly) stood at $2.0 million in 2020, then declined by 0.45% to $2.0 million in 2021, then soared by 282.49% to $7.6 million in 2022, then fell by 19.39% to $6.1 million in 2023, then climbed by 14.99% to $7.1 million in 2024.